Financial Personal
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
– Top-line data with unexpected results requiring further clarification, did not meet primary endpoint as per protocol – Potent growth hormone release following macimorelin stimulation – Safety of macimorelin confirmed in the pediat
About Macimorelin (Macrilen®; GHRYVELIN®) Read More